Moura FA, Fonseca Goulart MO. Chapter 7 - inflammatory bowel diseases: the crosslink between risk factors and antioxidant therapy. In: Gracia-Sancho J, Salvado J, eds. Maceio: Academic Press; 2017; 99–112.

Chapter  Google Scholar 

Henao MP, Bewtra M, Osterman MT et al. Measurement of inflammatory bowel disease symptoms: reliability of an abbreviated approach to data collection. Inflamm Bowel Dis. 2015;21:2262–2271.

PubMed  Google Scholar 

Kwon HJ, Dudley-Brown S, Williams M et al. Validation of a simple, patient directed, symptom based index for intestinal inflammation. J Clin Gastroenterol Treat. 2016;2:1–5.

Article  Google Scholar 

Benitez JM, Meuwis MA, Reenaers C et al. Role of endoscopy, cross-sectional imaging and biomarkers in Crohn’s disease monitoring. Gut. 2013;62:1806–1816.

Article  PubMed  Google Scholar 

Bray C, Bell LN, Liang H et al. Erythrocyte sedimentation rate and c-reactive protein measurements and their relevance in clinical medicine. WMJ. 2016;115:317–321.

PubMed  Google Scholar 

Hoekman DR, Diederen K, Koot BGP et al. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease. Eur J Pediatr. 2016;175:1335–1342.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Solem CA, Loftus EV, Tremaine WJ et al. Correlation of c-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:707–712.

Article  PubMed  Google Scholar 

Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterol. 2011;140:1817–1826.

Article  CAS  Google Scholar 

Wagatsuma K, Yokoyama Y, Nakase H. Role of biomarkers in the diagnosis and treatment of inflammatory bowel disease. Life. 2021;11:1375–1396.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mihai C, Prelipcean CC, Dranga M et al. Correlations between inflammatory biomarkers and activity in inflammatory bowel diseases. Rev Chim. 2018;69:710–713.

Article  CAS  Google Scholar 

Chang S, Malter L, Hudesman D. Disease monitoring in inflammatory bowel disease. World J Gastroenterol. 2015;21:11246–11259.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fagerberg UL, Lööf L, Myrdal U et al. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 2005;40:450–455.

Article  PubMed  Google Scholar 

Waugh N, Cummins E, Royle P et al. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess. 2013;17:1–212.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakurai T, Saruta M. Positioning and usefulness of biomarkers in inflammatory bowel disease. Digestion. 2023;104:30–41.

Article  CAS  PubMed  Google Scholar 

Boon GJ, Day AS, Mulder CJ et al. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease? World J Gastroenterol. 2015;21:11469–11480.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jha AK, Chaudhary M, Dayal VM et al. Optimal cut-off value of fecal calprotectin for the evaluation of ulcerative colitis: an unsolved issue? JGH Open. 2018;2:207–213.

Article  PubMed  PubMed Central  Google Scholar 

Sipponen T, Haapamäki J, Savilahti E et al. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn’s disease detected by wireless capsule endoscopy. Scand J Gastroenterol. 2012;47:778–784.

Article  CAS  PubMed  Google Scholar 

Thia K, Faubion WA, Loftus EV et al. Short CDAI: development and validation of a shortened and simplified Crohn’s disease activity index. Inflamm Bowel Dis. 2011;17:105–111.

Article  PubMed  Google Scholar 

Lewis JD, Chuai S, Nessel L et al. Use of the non-invasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660–1666.

Article  PubMed  Google Scholar 

Lewis JD. C-reactive protein: anti-placebo or predictor of response. Gastroenterol. 2005;129:1114–1116.

Article  CAS  Google Scholar 

Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer; 2016.

Book  Google Scholar 

R Core Team, R: A language and environment for statistical computing., R.F.f.S. Computing, Editor. 2021: Vienna, Austria.

Pinheiro J, Bates D, DebRoy S, Sarkar D. R Core Team., _nlme: Linear and Nonlinear Mixed Effects Models_. 2021.

Christensen RHB. _ordinal-Regression Models for Ordinal Data_. R Package version 2023: 12–4.

Colombel JF, Panaccione R, Bossuyt P et al. Effect of tight control management of Crohn’s disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet. 2017;390:2779–2789.

Article  PubMed  Google Scholar 

Bakkaloglu OK, Eskazan T, Celik S et al. Can we predict mucosal remission in ulcerative colitis more precisely with a redefined cutoff level of C-reactive protein? Colorectal Dis. 2022;24:77–84.

Article  CAS  PubMed  Google Scholar 

Walsh A, Kormilitzin A, Hinds C et al. Defining faecal calprotectin thresholds as a surrogate for endoscopic and histological disease activity in ulcerative colitis—a prospective analysis. J Crohns Colitis. 2019;19:424–430.

Article  Google Scholar 

Cartier A, Côté M, Lemieux I et al. Sex differences in inflammatory markers: what is the contribution of visceral adiposity? The Am J Clinl Nutr. 2009;89:1307–1314.

Article  CAS  Google Scholar